Resolute Science
San Diego, US · Founded 2020 · Delaware corporation · 1 known investors
Resolute Science appears to be a clinical-stage therapeutics company focused on oncology and cancer treatment development. The team includes medical oncologists, regulatory experts, and scientific advisors with experience in phase 1-3 clinical trials and precision medicine.
Founders & leadership
FB
Faith BarnettinExecutive
AB
Andre BasbaumNamed on SEC filing
Board
JM
James MackayBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 2 rounds · 2024–2025
▶$2.9MraisedApr 2026 · 25 investors · BiotechnologyRule 506(b)
▶$2.9MraisedApr 2026 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James MackayDirector
- Andre BasbaumExecutive Officer, Director
- Faith BarnettExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.9M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedMay 2024 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedMay 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andre BasbaumExecutive Officer
- Faith BarnettExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $250K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapSolu7 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Thumbnail for Seragon Pharmaceuticals7 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Resolve Therapeutics6 shared keywordsBiopharma company developing non-immunosuppressive drugs for autoimmune diseases.
Companies competing with Resolute Science for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Resolute Science do?
- Resolute Science appears to be a clinical-stage therapeutics company focused on oncology and cancer treatment development. The team includes medical oncologists, regulatory experts, and scientific advisors with experience in phase 1-3 clinical trials and precision medicine.
- Who are Resolute Science's investors?
- Resolute Science's investors include NuFund Venture Group.
- How much funding has Resolute Science raised?
- Resolute Science has disclosed $3.2M raised across 2 rounds.
- Where is Resolute Science headquartered?
- Resolute Science is headquartered in San Diego, US.
